Stay updated on Pediatric Ruxolitinib Cream PK in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Pediatric Ruxolitinib Cream PK in Atopic Dermatitis Clinical Trial page.

Latest updates to the Pediatric Ruxolitinib Cream PK in Atopic Dermatitis Clinical Trial page
- Check4 days agoChange DetectedCore study details and eligibility criteria appear unchanged; only minor visual layout differences are visible.SummaryDifference0.0%

- Check11 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision indicator updated to v3.4.2, replacing v3.4.1. No substantive content changes are indicated.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision tag updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check47 days agoChange DetectedThe updates are minor UI and metadata changes (show glossary option, updated QC-criteria wording, and version labels) that do not modify study data, eligibility, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page revision label was updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

Stay in the know with updates to Pediatric Ruxolitinib Cream PK in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Ruxolitinib Cream PK in Atopic Dermatitis Clinical Trial page.